Orphan Products

Orphan drugs are medicinal products expected for diagnosis, aversion or treatment of life-undermining or intense infections or scatters that are uncommon. An infection or disorder is characterized as uncommon in Europe when it influences under 1 in 2,000 residents. These medications are called "orphan" in light of the fact that under typical economic situations the pharmaceutical business has little enthusiasm for creating and promoting items expected for just a little number of patients. For medication organizations, the to a great degree high cost of offering a restorative item for sale to the public would not be recuperated by the normal offers of the item. Thus the potential market for new medication treatment is likewise little and the medication organizations industry would really cause a money related misfortune. In this way governments and uncommon sickness quiet associations, for example, EURORDIS advocate for monetary impetuses to urge medicate organizations to create and showcase solutions for rare disease treatment.

  • Acetaminophen, aspirin, and codeine phosphate
  • Actifed w/ codeine
  • Metreton
  • Mixtard human 70/30
  • Monobasic sodium phosphate and dibasic sodium phosphate

Related Conference of Orphan Products

December 02-03, 2020

2nd International Conference on Bio-Pharmaceuticals

Auckland, Newzealand
December 07-08, 2020

International Conference on Biotechnology and Healthcare

Auckland, Newzealand
December 16-16, 2020

21st World Conference on Pharmaceutical Chemistry and Drug Design

Singapore City, Singapore
December 16-16, 2020

22nd World Congress on Pharmacology, Nursing and Healthcare

Algeria, Algeria
January 22-23, 2021

1 st Global Summit on Generic Drugs and Quality Control

Prague, Czech Republic
January 22-23, 2021

1 st World Congress on Rare Diseases & Orphan Drugs

Prague, Czech Republic
February 26-27, 2021

2nd Annual Congress on Antibiotics and Bacterial Infections

Geneva, Switzerland
March 10-11, 2021

6th Pharmaceutical Chemistry Conference

Paris, France
March 16-17, 2021

14th Global Pharmacovigilance And Clinical Trials Summit

Albufeira, Portugal
April 11-12, 2021

2 nd World Pharma Expo

Tokyo, Japan
April 12-13, 2021

2nd International Conference on Biosimilars & Pharmaceuticals

Auckland, Newzealand
April 28-29, 2021

31st Annual European Pharma Congress

London, UK
April 28-29, 2021

14th European Biosimilars Congress

London, UK
May 10-11, 2021

20th Annual Meet on Pharmaceutical Sciences

Yokohama, Japan
May 17-18, 2021

8th European Biopharma Congress

Prague, Czech Republic
May 19-20, 2021

36th World Pharmacology and Therapeutics Forum

Singapore, Singapore
June 07-08, 2021

2rd European Conference on Pharmacovigilance and Drug Safety

Prague, Czech Republic
July 10-11, 2021

2 nd Pharma Expo China

Tokyo, Japan
August 16-17, 2021

Global summit on Cosmetic & Reconstructive Surgery

Tokyo, Japan
August 16-17, 2021

34rd World Congress on Pharmacology

London, UK
October 29-30, 2021

14th World Drug Delivery Summit

Vancouver, Canada
October 29-30, 2021

12th Annual Biomarkers and Clinical Research Congress

Vancouver, Canada

Orphan Products Conference Speakers

Recommended Sessions

Related Journals

Are you interested in